Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avatrombopag versus placebo for thrombocytopenia in chronic liver disease before elective procedures
2013-000965-34Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Thrombocytopenia and chronic liver disease (CLD) comparing Avatrombopag with Placebo (2 arms). Primary endpoint: Proportion of subjects who do not require a platelet transfusion or any rescue procedure for bleeding. Started Nov 2013; status: completed.
02
Drugs
avatrombopag
03
Conditions
Thrombocytopeniachronic liver disease (CLD)
Beyond the preview
Go deeper on 2013-000965-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000965-34.